Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
21.36
28.12
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Jiangsu Nhwa Pharmaceutical Co Ltd stock under the Base Case scenario is 31.36 CNY. Compared to the current market price of 26.46 CNY, Jiangsu Nhwa Pharmaceutical Co Ltd is Undervalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Jiangsu Nhwa Pharmaceutical Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Jiangsu Nhwa Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Jiangsu Nhwa Pharmaceutical Co Ltd
Balance Sheet Decomposition
Jiangsu Nhwa Pharmaceutical Co Ltd
Current Assets | 5.5B |
Cash & Short-Term Investments | 3.5B |
Receivables | 1.4B |
Other Current Assets | 660.8m |
Non-Current Assets | 2.2B |
Long-Term Investments | 157.6m |
PP&E | 1.5B |
Intangibles | 296.8m |
Other Non-Current Assets | 206.1m |
Current Liabilities | 828.7m |
Accounts Payable | 262.3m |
Accrued Liabilities | 94.4m |
Short-Term Debt | 193.7m |
Other Current Liabilities | 278.3m |
Non-Current Liabilities | 73m |
Long-Term Debt | 32.6m |
Other Non-Current Liabilities | 40.4m |
Earnings Waterfall
Jiangsu Nhwa Pharmaceutical Co Ltd
Revenue
|
5.4B
CNY
|
Cost of Revenue
|
-1.6B
CNY
|
Gross Profit
|
3.8B
CNY
|
Operating Expenses
|
-2.6B
CNY
|
Operating Income
|
1.2B
CNY
|
Other Expenses
|
-96.8m
CNY
|
Net Income
|
1.1B
CNY
|
Free Cash Flow Analysis
Jiangsu Nhwa Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Jiangsu Nhwa Pharmaceutical Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Jiangsu Nhwa Pharmaceutical Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jiangsu Nhwa Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Jiangsu Nhwa Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jiangsu Nhwa Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Jiangsu Nhwa Pharmaceutical Co Ltd is 32.95 CNY with a low forecast of 28.28 CNY and a high forecast of 37.8 CNY.
Dividends
Current shareholder yield for Jiangsu Nhwa Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the pharmaceutical production, research and development, and sales. The company is headquartered in Xuzhou, Jiangsu and currently employs 4,732 full-time employees. The company went IPO on 2008-07-23. The firm offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The firm is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Jiangsu Nhwa Pharmaceutical Co Ltd stock under the Base Case scenario is 31.36 CNY.
Compared to the current market price of 26.46 CNY, Jiangsu Nhwa Pharmaceutical Co Ltd is Undervalued by 16%.